This update adds revenue breakdown by business segment and includes 454’s contribution to fourth-quarter 2005 revenue not originally released.
NEW YORK (GenomeWeb News) — A CuraGen spokesperson today disclosed that the company’s 454 Life Sciences unit saw a 1.1-percet dip in total revenue during the fourth-quarter of 2006.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.